Skip to main content

Table 2 Characteristics of patients diagnosed with occult malignancy

From: “Best practices in risk reducing bilateral salpingo-oophorectomy: the influence of surgical specialty”

Patient

Mutation status

Age

Diagnosis

Prognosis

1

Unknown

45

Metastatic breast cancer to ovary (dx at RRBSO 2007)

Patient last seen 2011: diagnosis right femoral head metastases 2010 s/p XRT

2

Unknown

54

Leydig cell tumor of the ovary

Patient last seen 2012: no evidence of disease

3

Unknown

43

Metastatic breast cancer to ovary (known metastases to lymph nodes)

Lost to follow-up

4

Unknown

45

Metastatic breast cancer to ovary (known metastases to bone)

2010: new bone metastases; 2012: extensive bone mets, vertebral body compression fractures; 2017: stable lesions, on denosumab

5

BRCA1+

44

Papillary serous carcinoma of the fallopian tube

s/p 3 cycles carboplatin; no evidence of disease since 2009

6

BRCA+

44

Papillary serous carcinoma of the fallopian tube

s/p 6 cycles carboplatin/Taxol; no evidence of disease since 2009

7

BRCA2+

68

Papillary serous carcinoma of the fallopian tube

s/p carboplatin/Taxol × 3 cycles; no evidence of disease since 2007